Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $53.33 Average Target Price from Brokerages
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has been assigned an average recommendation of “Buy” from the nine brokerages that are covering the firm, Marketbeat reports. Nine analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have updated their coverage on the stock in the […]
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has been assigned an average recommendation of “Buy” from the nine brokerages that are covering the firm, Marketbeat reports. Nine analysts have rated the stock with a buy rating. The average twelve-month price objective among brokers that have updated their coverage on the stock in the […]
